Changes in Quality of Life for Pregnant Women in Substance User Treatment: Developing a Quality of Life Index for the Addictions

REFERENCES

• Phibbs C., Bateman D. A., Schwartz R. M. The neonatal cost of maternal cocaine use. JAMA 1991; 266: 1521–1525, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chasnoff I., Burns W. J., Schnoll S. Cocaine use in pregnancy. New. Engl. J. Med 1985; 313: 666–669, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Horgan C., Rosenbach M., Ostby E. Targeting Special Populations with Drug Abuse Problems: Pregnant Women. Drug Abuse Research Series No. 1, US Department of Health and Human Services, National Institute on Drug Abuse (NIDA), Washington, DC 1991
   Google Scholar
• Dicker M., Leighton E. A trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990. Am. J. Publ. Health 1994; 84: 1433–1438, [CSA]
   PubMedGoogle Scholar
• Breitbart V., Chavkin W., Wise P. H. The accessibility of drug treatment for pregnant women: a survey of programs in five cities. Am. J. Publ. Health 1994; 1658–1661
   PubMedGoogle Scholar
• Breyel J. M., Hill I. T. Creating Systems of Care for Substance-Using Pregnant Women and Their Children. National Governors' Association, Washington, DC 1993
   Google Scholar
• Howell E. M., Heiser N., Harrington M. A review of recent findings on substance abuse treatment for pregnant women. J. Subst. Abuse Treat. 1999; 16(3)195–219, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brolin M. F. Substance Abuse Treatment System Improvements and Treatment Outcomes. Commonwealth of Massachusetts, Department of Public Health, Bureau of Substance Abuse Services, Boston, MA 2000
   Google Scholar
• Brindis C., Berkowitz G., Clayson Z. Options for recovery: promoting perinatal drug and alcohol recovery. J. Drug Issues 1997; 27: 607–624, [CSA]
   Web of Science ®Google Scholar
• Camp J., Finkelstein N. Parenting training for women in residential substance abuse treatment. Results of a demonstration project. J. Subst. Abuse Treat 1997; 14(5)411–422, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clark H. W. Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications. Child Welfare 2001; 80: 179–198, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Comfort M. L., Kaltenbach K. A. Biopsychosocial characteristics and treatment outcomes of pregnant, cocaine-dependent women in residential and outpatient treatment. J. Psychoactiv. Drugs 1999; 31: 279–289, [CSA]
   PubMed Web of Science ®Google Scholar
• Cosden M., Peerson S., Elliott K. effects of prenatal drug exposure on birth outcomes and early childhood development. J. Drug Issues 1997; 27: 525–539, [CSA]
   Web of Science ®Google Scholar
• Daley M., Argeriou M., McCarty D., Shepard D. S., Callahan J. J., Williams C. N. The impact of treatment modality on birth weight, lifestyle changes and drug use in a sample of pregnant, drug-dependent women. J. Psychoactive Drugs 2001; 33: 57–66, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Daley M., Argeriou M., McCarty D., Shepard D. S., Callahan J. J., Williams C. N. The costs of crime and the benefits of substance abuse treatment programs for pregnant women. J. Subst. Abuse Treat. 2000; 19: 445–458, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Elk R., Mangus L. G., LaSoya R. J. Behavioral interventions: effective and adaptable for the treatment of pregnant, cocaine-dependent women. J. Drug Issues 1997; 27: 625–658, [CSA]
   Web of Science ®Google Scholar
• Haller D. L., Knisely J. S., Elswick R. K. Perinatal substance abusers: factors influencing treatment retention. J. Subst. Abuse Treat. 1997; 14: 513–519, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Laken M. P., McComish J. F., Ager J. Predictors of prenatal substance use and birth weight during outpatient treatment. J. Subst. Abuse Treat. 1997; 14: 359–366, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schrager M. A., Joyce J., Cawthon L. Substance Abuse Treatment and Birth Outcomes for Pregnant and Postpartum Women in Washington State. State of Washington, Department of Health and Social Services, Olympia, WA 1995
   Google Scholar
• Stevens S. J., Arbiter N. A therapeutic community for substance abusing pregnant women and women with children: process and outcome. J. Psychoactive Drugs 1995; 27: 49–56, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zlotnick C., Franchino K., Claire N., St. The impact of outpatient drug services on abstinence among pregnant and parenting women. J. Subst. Abuse Treat 1996; 13: 195–202, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eisen M., Keyser-Smith J., Dampeer J. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment. Addict. Behav. 2000; 25: 123–129, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chavkin W., Paone D., Friedmann P. Psychiatric histories of drug-using mothers: treatment implications. J. Subst. Abuse Treat. 1993; 10: 445–448, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Daley M., Argeriou M. Characteristics and treatment needs of sexually abused pregnant women in substance abuse treatment. J. Subst. Abuse Treat. 1997; 14: 191–196, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Finkelstein N. Treatment programming for alcohol and drug-dependent pregnant women. Int. J. Addictions. 1993; 8: 1275–1309
   Google Scholar
• Ingersoll K. S., Dawson K., Haller D. L. Family functioning of perinatal substance abusers in treatment. J. Psychoactive Drugs 1996; 28: 61–71, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Drummond M. P., Stoddard G. L., Torrance G. W. Methods for the Economic Evaluation of Health Programs. Oxford University Press, , New York 1986
   Google Scholar
• Feeny D. H., Torrance G. W., Furlong W. J. Health Utilities Index. In Quality of Life and Pharmacoeconomics in Clinical Trials2nd, B. Spilker. Lippincott-Raven, Philadelphia, PA 1995
   Google Scholar
• Kamlet M. S., Wade M., Kupfer D. J. Cost-Utility Analysis of Treatment Programs for Recurrent Depression. Fifth Biennial Conference on the Economics of Mental Health, Annapolis, MD, June, 25–261990
   Google Scholar
• Gold M., Siegal J., Russell L. B., Weinstein M. C. Cost-Effectiveness in Health and Medicine Oxford University Press, New York, NY 1996
   Google Scholar
• Kind P. The Euro-Qol Instrument: an Index of Health Related Quality of Life. In Quality of Life and Pharmacoeconomics in Clinical Trials;2nd, B. Spilker. Lippincott-Raven, Philadelphia, PA 1995
   Google Scholar
• French M. T. economic evaluation of drug treatment programs: methodology and findings. Am. J. Drug Alc. Abuse 1995; 21: 111–135, [CSA]
   PubMed Web of Science ®Google Scholar
• McLellan A. T., Kushner J., Metzger D. The fifth edition of the addiction severity index. J. Subst. Abuse Treat 1992; 9: 199–213, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Metzger D. S., Davis R. F., O'Brien C. P. Substance Abuse Disorders. In Quality of Life and Pharmacoeconomics in Clinical Trials2nd, B. Spilker. Lippincott-Raven, Philadelphia, PA 1995
   Google Scholar
• Longabaugh R. Measuring quality of life in alcohol treatment programs. J. Stud. Alcohol 1992; 81: 1335–1342
   Google Scholar
• Von Neumann J., Morgenstern O. Theory of Games and Economic Behavior. Princeton University Press, Princeton, NJ 1947
   Google Scholar
• Keeney R. L., Raiffa H. Decisions with Multiple Objectives: Preferences and Trade-Offs. John Wiley and Sons, , New York 1976
   Google Scholar
• Argeriou M., Daley M. The Massachusetts MOTHERS Project: An Evaluation of Residential Treatment for Pregnant Substance Abusers. Health Care Financing Administration (HCFA) Cooperative Agreement No. 11-C-06111/1-05., Health and Addictions Research, Inc., Boston, MA 1997, Oct 31
   Google Scholar
• Shepard D. S., Larson M. J., Hoffmann N. C. Cost-effectiveness of substance abuse treatment services: implications for social policy. Psych. Clin. North. Am 1998; 22: 385–400, [CSA]
   Google Scholar
• SAS/STAT Software. Release 6.12, SAS Institute, Cary, NC 1996
   Google Scholar
• Bury-Maynard D. Brandeis University, Waltham, MA 1999, Developing A Utility Index For Substance Abuse. Ph.D. Dissertation, Heller Graduate School for Social Policy and Management
   Google Scholar
• Inciardi J. A., Poettieger A. E. Drug use and street crime in miami: an (almost) twenty-year retrospective. Subst. Use Misuse 1998; 33: 1839–1870, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Joyce T., Racine A. D., McCalla S., Wehbeh H. The impact of prenatal exposure to cocaine on newborn costs and length of stay. Health Serv. Res. 1995; 30(2)341–358, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Schildhaus S., Gerstein D., Ray B., Michie J. Services Research Outcomes Study. DHHS Publication No. SMA-98-3177, U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, Rockville, MD 1998
   Google Scholar
• Lyons P., Rittner B. The construction of the crack babies phenomenon as a social problem. Am. J. Orthopsych 1998; 68: 313–320, [CSA]
   Google Scholar